1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)
Metabolic inactivation of noradrenaline in human placenta, umbilical cord and fetal membranes
Article first published online: 23 AUG 2005
DOI: 10.1111/j.1471-0528.1983.tb08960.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b "BJOG: An International Journal of Obstetrics & Gynaecology")
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 90, Issue 6, pages 525–527, June 1983
Additional Information
How to Cite
SAARIKOSKI, S. (1983), Metabolic inactivation of noradrenaline in human placenta, umbilical cord and fetal membranes. BJOG: An International Journal of Obstetrics & Gynaecology, 90: 525–527. doi: 10.1111/j.1471-0528.1983.tb08960.x
Publication History
- Issue published online: 23 AUG 2005
- Article first published online: 23 AUG 2005
- Received 16 August 1982 Accepted 5 January 1983
- Abstract
- References
- Cited By
Summary. Metabolic inactivation of noradrenaline (NA) was studied in human placenta, umbilical vessels, Wharton's jelly and fetal membranes. Highest degradation capacity was observed in the placenta and fetal membranes, where the NA was inactivated by both monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT). No MAO and COMT activity was found in the cord jelly and the activities in umbilical vessels were very low.